Clinical and Economic Effectiveness of an Inpatient Anticoagulation Service
dc.contributor.author | Mamdani, Muhammad M. | en_US |
dc.contributor.author | Racine, Eric | en_US |
dc.contributor.author | McCreadie, Scott | en_US |
dc.contributor.author | Zimmerman, Chris | en_US |
dc.contributor.author | O'Sullivan, Tami L. | en_US |
dc.contributor.author | Jensen, Gail | en_US |
dc.contributor.author | Ragatzki, Paul | en_US |
dc.contributor.author | Stevenson, James G. | en_US |
dc.date.accessioned | 2012-03-16T15:57:58Z | |
dc.date.available | 2012-03-16T15:57:58Z | |
dc.date.issued | 1999-09 | en_US |
dc.identifier.citation | Mamdani, Muhammad M.; Racine, Eric; McCreadie, Scott; Zimmerman, Chris; O'Sullivan, Tami L.; Jensen, Gail; Ragatzki, Paul; Stevenson, James G. (1999). "Clinical and Economic Effectiveness of an Inpatient Anticoagulation Service." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 19(9). <http://hdl.handle.net/2027.42/90256> | en_US |
dc.identifier.issn | 0277-0008 | en_US |
dc.identifier.issn | 1875-9114 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/90256 | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.title | Clinical and Economic Effectiveness of an Inpatient Anticoagulation Service | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | College of Pharmacy, University of Michigan, Ann Arbor, Michigan. | en_US |
dc.contributor.affiliationum | University of Michigan Medical Center, Ann Arbor, Michigan. | en_US |
dc.contributor.affiliationother | Institute for Clinical Evaluation Sciences and the University of Toronto, Toronto, Ontario, Canada | en_US |
dc.contributor.affiliationother | College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, Michigan | en_US |
dc.contributor.affiliationother | Department of Economics, Wayne State University, Detroit, Michigan. | en_US |
dc.contributor.affiliationother | School of Medicine, Wayne State University, Detroit, Michigan. | en_US |
dc.contributor.affiliationother | Department of Pharmacy, Harper Hospital, Detroit Medical Center, Detroit, Michigan | en_US |
dc.contributor.affiliationother | Detroit Receiving Hospital, Detroit Medical Center, Detroit, Michigan. | en_US |
dc.contributor.affiliationother | Department of Pharmacy, Henry Ford Hospital, Detroit, Michigan. | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/90256/1/phco.19.13.1064.31591.pdf | |
dc.identifier.doi | 10.1592/phco.19.13.1064.31591 | en_US |
dc.identifier.source | Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | en_US |
dc.identifier.citedreference | Clagett GP, Reisch JS. Prevention of venous thromboembolism. Chest 1992; 102: 391S – 407. | en_US |
dc.identifier.citedreference | Goldhaber S.. Thrombolysis for pulmonary embolism. Prog Cardiovasc Dis 1991; 34: 113 – 34. | en_US |
dc.identifier.citedreference | Salzman EW, Hirsh J.. The epidemiology, pathogenesis and natural history of venous thromboembolism. In: Coleman RW, Hirsh J., Marder VJ, Salzman EW, eds. Hemostasis and thrombosis. Philadelphia: JB Lippincott, 1994: 1275 – 96. | en_US |
dc.identifier.citedreference | Anderson FA Jr, Wheeler HB, Goldberg RJ, et al. A population‐based perspective of the hospital incidence and the case‐fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT study. Arch Intern Med 1991; 151: 933 – 8. | en_US |
dc.identifier.citedreference | Hirsh J., Raschke R., Warkentin TE, Dalen JE, Deykin D., Poller L.. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1995; 108 ( 4 ): 258S – 75. | en_US |
dc.identifier.citedreference | Hull RD, Raskob GE, Hirsh J., et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal deep vein thrombosis. N Engl J Med 1986; 315: 1109 – 14. | en_US |
dc.identifier.citedreference | Raschke RA, Reilly BM, Guidry J.R., Fontana J.R., Srinivas S.. The weight‐based heparin dosing nomogram compared with a “standard care” nomogram. Ann Intern Med 1993; 119: 874 – 81. | en_US |
dc.identifier.citedreference | Cipolle RJ, Rodvold KA. Heparin. In: Evans WE, Schentag JJ, Jusko W., eds. Applied pharmacokinetics. Spokane, WA: Applied Therapeutics, 1986: 908 – 42. | en_US |
dc.identifier.citedreference | Reilly BM, Raschke RA, Srinivas S., Nieman T.. Intravenous heparin dosing: patterns and variations in internists' practices. J Gen Intern Med 1993; 8: 536 – 42. | en_US |
dc.identifier.citedreference | Wheeler AP, Jaquiss RDB, Newman JH. Physician practices in the treatment of pulmonary embolism and deep vein thrombosis. Arch Intern Med 1988; 148: 1321 – 5. | en_US |
dc.identifier.citedreference | Nemeth JS, Marxen TL, Piltz GW. Weight‐based protocol for improving heparin therapy. Am J Health-Syst Pharm 1996; 53: 1164 – 6. | en_US |
dc.identifier.citedreference | Shalansky KF, Fitzgerald JM, Sunderji R., et al. Comparison of a weight‐based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation. Pharmacotherapy 1996; 16 ( 6 ): 1076 – 84. | en_US |
dc.identifier.citedreference | Hull RD, Raskob GE, Rosenbloom D., et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990; 322: 1260 – 4. | en_US |
dc.identifier.citedreference | Fennerty A., Dolben J., Thomas P., et al. Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J 1984; 288: 1268 – 70. | en_US |
dc.identifier.citedreference | Cogo A., Bernardi E., Prandoni E., et al. Acquired risk factors for deep vein thrombosis in symptomatic patients. Arch Intern Med 1994; 154: 164 – 8. | en_US |
dc.identifier.citedreference | Carson JL, Kelley MA, Duff A., et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326: 1240 – 5. | en_US |
dc.identifier.citedreference | Schafer AI. The hypercoaguable states. Ann Intern Med 1985; 102: 814 – 28. | en_US |
dc.identifier.citedreference | Hull RD, Raskob GE, Rosenbloom D., et al. Optimal therapeutic level of heparin therapy in patients with venous thromboembolism. Arch Intern Med 1992; 152: 1589 – 95. | en_US |
dc.identifier.citedreference | Charlson ME, Pompei P., Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373 – 83. | en_US |
dc.identifier.citedreference | Jacobs P.. Economic measurement: cost‐benefit and cost‐effectiveness analysis. In: The economics of health and medical care, 3rd ed. Gaithersburg, MD: Aspen, 1991: 353. | en_US |
dc.identifier.citedreference | Zimmerman CR, Smolarek RT, Stevenson JG. A computerized system to improve documentation and reporting of pharmacists' clinical interventions, cost savings, and workload activities. Pharmacotherapy 1995; 15: 220 – 7. | en_US |
dc.identifier.citedreference | Fisher LD, van Belle G.. Biostatistical design of medical studies. In: Biostatistics: a methodology for the health sciences. New York: John Wiley & Sons, 1993: 18. | en_US |
dc.identifier.citedreference | Hennekens CH, Buring JE. Epidemiology in medicine. Boston: Little, Brown, 1987. | en_US |
dc.identifier.citedreference | Ellrodt AG, Conner L., Riedinger M., Weingarten S.. Measuring and improving physician compliance with clinical practice guidelines. Ann Intern Med 1995; 122: 277 – 82. | en_US |
dc.identifier.citedreference | Levine M., Gent M., Hirsh J., et al. A comparison of low‐molecular‐weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep‐vein thrombosis. N Engl J Med 1996; 334: 677 – 81. | en_US |
dc.identifier.citedreference | Koopman MMW, Prandoni P., Piovella F., et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low‐molecular‐weight heparin administered at home. N Engl J Med 1996; 334: 682 – 7. | en_US |
dc.identifier.citedreference | Anonymous.. Informed Newsletter. Toronto, Ontario, Canada: Institute for Clinical Evaluative Sciences, Sunnybrook Medical Center 1996; 3 ( 1 ). | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.